Pulmonic valve regurgitation occurs when blood leaks abnormally backward from the pulmonary artery through the pulmonic valve into the right ventricle. This can result in right heart failure. Pulmonic ...

Hello and greetings from Bronx, New York. This is Ronald Wharton. I am a cardiologist at Montefiore Medical Center and the Albert Einstein College of Medicine. I thought I'd share with you something ...

The findings come on the heels of the US Food and Drug Administration approving the Harmony system (Medtronic) in March as the first nonsurgical heart valve to treat pulmonary valve regurgitation in ...

Edwards Lifesciences announced the approval Monday for management of both pediatric and adult patients with severe pulmonary regurgitation on echocardiography who are candidates for surgical ...

In patients with postoperative right ventricular outflow tract conduit dysfunction and significant baseline tricuspid regurgitation, transcatheter pulmonary valve replacement appears to yield ...

Ronald H. Wharton, MD: Greetings. This is Ronald Wharton. I am a cardiologist at Montefiore Medical Center, Bronx, New York, and assistant professor of medicine at the Albert Einstein College of ...

RAPID advances in surgery have made an understanding of the significance of any potentially correctable valvular defect as important as the ability to establish an exact diagnosis. As an isolated ...

Edwards Lifesciences is closing out 2021 by nabbing a new approval from FDA. The Irvine, CA-based company said it won the nod for the use of the Edwards Sapien 3 transcatheter valve with the Alterra ...

A study of one year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR) was ...

The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...

A large study revealed that severe valvular heart disease is common among cancer patients and is associated with poorer survival outcomes.A large study has found that severe valvular heart disease is ...